open access
Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor
, 1
Affiliations- School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland, Department of Internal Medicine, Diabetology, and Nephrology
open access
Abstract
Abstract
Keywords
weight loss; diabetes; SGLT-2 inhibitor
About this articleTitle
Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor
Journal
Issue
Article type
Clinical vignette
Pages
522-523
Published online
2019-10-23
Page views
1350
Article views/downloads
869
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2019;70(6):522-523.
Keywords
weight loss
diabetes
SGLT-2 inhibitor
Authors
Edyta Cichocka
Janusz Gumprecht
References (5)- Diabetology C. 2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet. 2018; 7(1): 1–90.
- Chao EC. SGLT-2 Inhibitors: A New Mechanism for Glycemic Control. Clin Diabetes. 2014; 32(1): 4–11.
- Cai X, Yang W, Gao X, et al. The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis. Obesity (Silver Spring). 2018; 26(1): 70–80.
- Thewjitcharoen Y, Yenseung N, Malidaeng A, et al. Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center. Diabetol Metab Syndr. 2017; 9: 96.
- Ferrannini G, Hach T, Crowe S, et al. Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015; 38(9): 1730–1735.
